Cartalax
Cartilage & connective tissue Research only Animal studies Synthetic short peptide (Cytogen)
Also called AED peptide, T-31
A three-amino-acid Khavinson peptide associated with cartilage and connective tissue. In cell studies it changed markers of cell division and aging in fibroblasts, such as Ki-67 and p53, and is described as slowing cellular aging in skin and kidney cell cultures.
Evidence at a glance
- Evidence
- Animal studies — Not yet studied in people
- Status
- Research compound only
- Dosing
- No human study has set a dose
Cell culture only, one research group.
What studies report
- Changed cell division and senescence markers (Ki-67, p53) in cultured fibroblasts
- Described as slowing cellular aging in skin and kidney cell cultures
How it works
A Khavinson short peptide: at two to four amino acids it is small enough to pass through cell and nuclear membranes intact. The proposed mechanism is that it binds specific sites on nuclear DNA and changes which genes are switched on in its target tissue, rather than acting on a surface receptor the way most peptides do.
Where it acts
Joints & cartilageThe library groups this compound under Cartilage & connective tissue. The diagram shows that target, not every tissue it reaches.
Illustrated

AI-generated subject illustration; not a depiction of the compound or evidence of its effects.
Why people take it
Reasons people seek it out — not a list of proven effects.
Status: Cell-culture data, mostly from one research group.
- Route
- Subcutaneous injection, or oral capsule depending on the preparation
- Sequence
- Ala-Glu-Asp
- Formula
- C12H19N3O8
- Molecular weight
- 333.29 g/mol
- Available as
- 20 mg
Search PubMed for Cartalax → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.
Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.